Bridge to transplant experience: Factors influencing survival to and after cardiac transplant
Presented at the 87th annual meeting of the American Association for Thoracic Surgery, May 5–9, 2007, Washington, DC.
Received 3 May 2007; received in revised form 13 November 2009; accepted 7 December 2009.
Objective
Balancing longer duration of mechanical circulatory support while awaiting functional recovery against the increased risk of adverse events with each day on support is difficult. Therefore, we investigated the complex interplay of duration of mechanical circulatory support and patient and device factors affecting survival on support, as well as survival after transplantation.
Methods
From December 21, 1991, to July 1, 2006, mechanical circulatory support was used in 375 patients as a bridge to transplantation, with 262 surviving to transplant. Implantable pulsatile devices were used in 321 patients, continuous flow was used in 11 patients, a total artificial heart was used in 5 patients, external pulsatile devices were used in 34 patients, and extracorporeal membrane oxygenation was used in 68 patients. Two time-related models were developed: (1) a competing-risks multivariable model of death on mechanical circulatory support, with modulated renewal for each sequential support mode; and (2) a model of death after transplant in which patient factors and duration of mechanical circulatory support were investigated as risk factors.
Results
Survival after initiating mechanical circulatory support, irrespective of transplantation, was 86% at 30 days, 55% at 5 years, and 41% at 10 years; survival was 94%, 74%, and 58% at the same time intervals, respectively, after transplantation in those surviving the procedure. Risk factors for death included longer, but not shorter, duration of mechanical circulatory support, use of multiple devices, global sensitization, and poor renal function.
Conclusion
Initiating mechanical circulatory support early with a single definitive device may improve survival to and after cardiac transplantation. Early transplant, which avoids infection, sensitization, and neurologic complications, may improve bridge and transplant survival.
eDepartment of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio
Address for reprints: Nicholas G. Smedira, MD, Surgical Director, Kaufman Center for Heart Failure, Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic, 9500 Euclid Avenue/J4-1, Cleveland, OH 44195.
D.Y.Y. supported by the American Heart Association Pre-doctoral Fellowship. E.H.B. supported in part by the Kenneth Gee and Paula Shaw, PhD, Chair in Heart Research.
ABSTRACT